Literature DB >> 34181823

Treatment decisions after interdisciplinary evaluation for nonarthritic hip pain: A randomized controlled trial.

Lindsey Brown-Taylor1,2,3, Marcie Harris-Hayes4, Randi Foraker5, William Kelton Vasileff1,6, Kathryn Glaws1, Stephanie Di Stasi1,2.   

Abstract

BACKGROUND: Physical therapy and hip arthroscopy are two viable treatment options for patients with nonarthritic hip pain (NAHP); however, patients may experience considerable decisional conflict when making a treatment decision. Interdisciplinary evaluation with a physical therapist and surgeon may better inform the decision-making process and reduce decisional conflict.
OBJECTIVE: To identify the extent to which an interdisciplinary evaluation between a surgeon, physical therapist, and patient influences treatment plans and decisional conflict of persons with NAHP.
DESIGN: Randomized controlled trial.
SETTING: Hip preservation clinic. PARTICIPANTS: Adults with primary NAHP.
INTERVENTIONS: Participants were randomized to receive a standard (surgeon) or interdisciplinary (surgeon+physical therapist) evaluation. Surgeon evaluations included patient interview, strength and range-of-motion examination, palpation, gross motor observation, and special testing. Interdisciplinary evaluations started with the surgeon evaluation, then a physical therapist evaluated movement impairments during sitting, sit-to-stand, standing, single-leg stance, single-leg squat, and walking. All evaluations concluded with treatment planning with the respective provider(s). OUTCOME MEASURES: Treatment plan and decisional conflict were collected pre- and postevaluation. Inclusion of physical therapy in participants' postevaluation treatment plans and postevaluation decisional conflict were compared between groups using chi-square tests and Mann-Whitney U tests, respectively.
RESULTS: Seventy-eight participants (39 in each group) met all eligibility criteria and were included in all analyses. Sixty-six percent of participants who received an interdisciplinary evaluation included physical therapy in their postevaluation treatment plan, compared to 48% of participants who received a standard evaluation (p = .10). Participants who received an interdisciplinary evaluation reported 6.3 points lower decisional conflict regarding their postevaluation plan (100-point scale; p = .04). The interdisciplinary and standard groups reduced decisional conflict on average 24.8 ± 18.9 and 23.6 ± 14.6 points, respectively.
CONCLUSIONS: Adding a physical therapist to a surgical clinic increased interest in physical therapy treatment, but this increase was not statistically significant. The interdisciplinary group displayed lower postevaluation decisional conflict; however, both groups displayed similar reductions in decisional conflict from pre- to postevaluation. This study also demonstrated the feasibility of an interdisciplinary evaluation in a hip preservation clinic.
© 2021 American Academy of Physical Medicine and Rehabilitation.

Entities:  

Mesh:

Year:  2021        PMID: 34181823      PMCID: PMC8712617          DOI: 10.1002/pmrj.12661

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  44 in total

1.  [''R"--project for statistical computing].

Authors:  Ram Benny Dessau; Christian Bressen Pipper
Journal:  Ugeskr Laeger       Date:  2008-01-28

2.  Patient involvement and shared decision-making in the management of back pain: a proposed multidisciplinary team model.

Authors:  A Nanapragasam; C K Lim; G Maskell
Journal:  Clin Radiol       Date:  2018-10-23       Impact factor: 2.350

Review 3.  Lower limb biomechanics in femoroacetabular impingement syndrome: a systematic review and meta-analysis.

Authors:  Matthew G King; Peter R Lawrenson; Adam I Semciw; Kane J Middleton; Kay M Crossley
Journal:  Br J Sports Med       Date:  2018-02-13       Impact factor: 13.800

4.  Validation of a decisional conflict scale.

Authors:  A M O'Connor
Journal:  Med Decis Making       Date:  1995 Jan-Mar       Impact factor: 2.583

Review 5.  A systematic review of effectiveness of decision aids to assist older patients at the end of life.

Authors:  Magnolia Cardona-Morrell; Gustavo Benfatti-Olivato; Jesse Jansen; Robin M Turner; Diana Fajardo-Pulido; Ken Hillman
Journal:  Patient Educ Couns       Date:  2016-10-11

6.  The Development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33).

Authors:  Nicholas G H Mohtadi; Damian R Griffin; M Elizabeth Pedersen; Denise Chan; Marc R Safran; Nicholas Parsons; Jon K Sekiya; Bryan T Kelly; Jason R Werle; Michael Leunig; Joseph C McCarthy; Hal D Martin; J W Thomas Byrd; Marc J Philippon; Robroy L Martin; Carlos A Guanche; John C Clohisy; Thomas G Sampson; Mininder S Kocher; Christopher M Larson
Journal:  Arthroscopy       Date:  2012-05       Impact factor: 4.772

7.  Abnormal Joint Moment Distributions and Functional Performance During Sit-to-Stand in Femoroacetabular Impingement Patients.

Authors:  Michael A Samaan; Benedikt J Schwaiger; Matthew C Gallo; Thomas M Link; Alan L Zhang; Sharmila Majumdar; Richard B Souza
Journal:  PM R       Date:  2016-10-08       Impact factor: 2.298

8.  Prediction of health professionals' intention to screen for decisional conflict in clinical practice.

Authors:  France Légaré; Ian D Graham; Annette C O'Connor; Michèle Aubin; Lucie Baillargeon; Yvan Leduc; Jean Maziade
Journal:  Health Expect       Date:  2007-12       Impact factor: 3.377

9.  Fate of the ACL-injured patient. A prospective outcome study.

Authors:  D M Daniel; M L Stone; B E Dobson; D C Fithian; D J Rossman; K R Kaufman
Journal:  Am J Sports Med       Date:  1994 Sep-Oct       Impact factor: 6.202

10.  Feasibility and Efficacy of Decision Aids to Improve Decision Making for Postmastectomy Breast Reconstruction: A Systematic Review and Meta-analysis.

Authors:  Nicholas L Berlin; Vickram J Tandon; Sarah T Hawley; Jennifer B Hamill; Mark P MacEachern; Clara N Lee; Edwin G Wilkins
Journal:  Med Decis Making       Date:  2019-01       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.